TABLE 3.
Postoperative rehabilitation of the MDS and TDS groups after PSM
| Characteristics | MDS group (n = 120) | TDS group (n = 120) | T/χ 2 | p |
|---|---|---|---|---|
| Chest tube duration a (h) | 0.00 ± 0.00 | 32.68 ± 18.51 | −19.337 | 0.000 |
| Total drainage volume (ml) | 143.03 ± 118.33 | 187.73 ± 140.82 | −2.663 | 0.008 |
| Number of additional pain relief b | 0.14 ± 0.40 | 0.42 ± 0.74 | −3.591 | 0.000 |
| Facial pain score (postoperative day 1) | 2.7 ± 1.8 | 3.6 ± 2.7 | 2.829 | 0.005 |
| CTCAE 1 complications | 94 | 70 | 11.091 | 0.001 |
| Subcutaneous emphysema c | 61 (50.8) | 49 (40.8) | 2.417 | 0.120 |
| Pneumothorax | 33 (27.5) | 21 (17.5) | 3.441 | 0.064 |
| CTCAE 2 complications | ||||
| Pulmonary infection d | 3 (2.5) | 4 (3.3) | 0.000 | 1.000 |
| Postoperative hospital stay (days) | 2.61 ± 0.70 | 3.27 ± 1.88 | −3.598 | 0.000 |
| Incision adverse events e | 3 (2.5%) | 10 (8.3%) | 3.985 | 0.046 |
| Total in‐hospital costs | 30 197.94 ± 24 019.53 | 32 619.73 ± 5809.62 | −1.074 | 0.284 |
a
Chest tube duration refers to the duration of the thoracic closed drainage tube through the fourth intercostal incision.
b
The number of additional pain relief according to the times of using additional painkillers in the doctor's advice.
c
For the convenience of statistics, subcutaneous emphysema was confirmed by postoperative chest X‐ray.
d
Pulmonary infection refers to postoperative fever ≥38°C, leukocytosis, and lung inflammation revealed in chest X‐ray.
e
Incision adverse events refer to poor incision healing.